Dachaigh › Dermatitis Atopach (Eczema) › Alabama › Birmingham
Sgrùdaidhean clionaigeach Dermatitis Atopach (Eczema) ann an Birmingham, AL
Tha 9 sgrùdaidhean airson Dermatitis Atopach (Eczema) a’ lorg phàirtichean aig làraichean ann agus timcheall air Birmingham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A’ fastadhSgrùdadh amharc
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
A’ fastadhÌre 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
A’ fastadhÌre 3
- Cahaba Dermatology & Skin Health Center, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
A’ fastadhÌre 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A’ fastadhÌre 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
A’ fastadhÌre 2
- Allervie Clinical Research, Birmingham
Sgrùdaidhean Dermatitis Atopach (Eczema) ann am bailtean eile
- New York City, NY13 sgrùdaidhean
- Los Angeles, CA11 sgrùdadh
- Washington, DC11 sgrùdadh
- San Antonio, TX10 sgrùdaidhean
- San Diego, CA10 sgrùdaidhean
- Miami, FL9 sgrùdaidhean
- Dallas, TX8 sgrùdaidhean
- Huntington Beach, CA8 sgrùdaidhean
- Sacramento, CA8 sgrùdaidhean
- Troy, MI8 sgrùdaidhean
- Indianapolis, IN7 sgrùdaidhean
- Pittsburgh, PA7 sgrùdaidhean
Sgrùdaidhean eile ann an Birmingham
- Aillse (gach seòrsa)31 sgrùdaidhean
- Aillse a' bhroilleach24 sgrùdaidhean
- Cancer Ovarian23 sgrùdaidhean
- Obesity23 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag22 sgrùdaidhean
- Leukemia myeloid geur21 sgrùdaidhean
- Myeloma iomaill18 sgrùdaidhean
- COPD17 sgrùdaidhean
- Galarachd Cardiovasculach17 sgrùdaidhean
- Diabaitis Seòrsa 216 sgrùdaidhean
- Ailse Endometrial16 sgrùdaidhean
- Ro-throm16 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.